The AndroGel (testosterone gel) brand and generic had US sales of approximately USD 815.6m MAT for the most recent twelve months ending in February 2019 according to IQVIA Health.
Dr. Reddy's Testosterone Gel 1.62% (20.25 mg/1.25 g pump actuation) is available in a net quantity of 88 g pump which dispenses 20.25 mg of testosterone per actuation. Each metered-dose pump is capable of dispensing 60 metered pump actuations.
AndroGel is a trademark of AbbVie Inc.
Dr. Reddy's Laboratories is an integrated pharmaceutical company, with a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic
ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA
International Isotopes Inc to change name to Radnostix Inc
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval
EirGenix signs second global exclusive licensing deal with Sandoz
Padagis invests USD36m to expand manufacturing in Minneapolis
Newbury Pharmaceuticals gains Danish approval for generic ivermectin cream